Cite
HARVARD Citation
Curry, N. et al. (2019). Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). Haemophilia. 25 (3), pp. 373-381. [Online].